A clinical trial to verify the accuracy of Seers Technology’s pulse oximeter (mobiCARE +Pulse, MP100W) in healthy volunteers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008376

Enrollment

Registered

2023-04-21

Start date

2023-05-13

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Volunteers were monitored using end-tidal carbon dioxide partial pressure and fraction of inspired oxygen by using Carescape® B850 (GE Healthcare, Milwaukee, WI, USA). Each volunteer was plac

Radiometer Medical A/S, Copenhagen, Denmark) were used as a reference for the SpO2 accuracy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -healthy adults between 20 and 50 years -volunteers who have plasma proportion of carboxyhemoglobin 3% -volunteers who have plasma proportion of methemoglobin 2% -volunteers who have total plasma hemoglobin concentration over 10 g/dL

Exclusion criteria

Exclusion criteria: -History of respiratory diseases -History of cardiovascular disease -Smokers (including ex-smokers) -Pregnant -History of fainting -History of diabetes -Obesity (BMI> 30 kg/m2) -Allen’s test results, those who do not recover the color of their fingers and palms within 10 seconds - History of allergic reaction to lidocaine, a local anesthetic

Design outcomes

Primary

Measure	Time frame
The root-mean-square of the difference between the observed pulse oximetry value (SpO2) and the carbon monoxide-oxygenometer arterial blood reference value (SRi) within the range of 70-100% of arterial oxygen saturation	—

Secondary

Measure	Time frame
safety	—

Countries

Korea, Republic of

Contacts

Public ContactByung-Moon Choi

Asan Medical Center

byungmoonchoi7@gmail.com+82-2-3010-1704

Outcome results